FiercePharmaOriginal article
{"a":[{"_":"Sanofi strikes Cheplapharm deal to divest 20 older medicines as CEO pushes for innovation","$":{"href":"/pharma/sanofi-strikes-deal-cheplapharm-divest-20-older-medicines-new-ceos-push-innovation","hreflang":"en"}}]}
Positive
AI Analysis
Summary
Sanofi divests 20 mature medicines and three manufacturing sites to German drugmaker Cheplapharm while acquiring a 26.4% stake in the company, allowing Sanofi to shed legacy assets and focus on innovation.
Importance:6/10
Sentiment:
0.50
M&Aasset_divestituremature_productsportfolio_optimizationstrategic_partnership
Related Companies
Read the original article
Published by FiercePharma on September 15, 2026 9:57 AM
